Atika Capital Management LLC

Holdings History for Coherus Oncology, Inc. - Common Stock, par value $0.0001 per share (CHRS)

Symbol: CHRS on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2020		-0.68%	$0	0	-195,000	-100%	$2.22	Q2 2020
31 Mar 2020	0.68%	0%	$3,163,000	195,000	0		$16.22	Q1 2020
31 Dec 2019	0.75%	+0.04%	$3,511,000	195,000	+9,500	+5.1%	$18.01	Q4 2019
30 Sep 2019	0.98%	-0.13%	$3,758,000	185,500	-24,500	-12%	$20.26	Q3 2019
30 Jun 2019	1%	+0.11%	$4,641,000	210,000	+22,000	+12%	$22.10	Q2 2019
31 Mar 2019	0.73%	+0.73%	$2,564,000	188,000	+188,000	NEW	$13.64	Q1 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.